Friederike M. Dannheim

Friederike M. Dannheim

Auto-generated profile, based on publicly available information

Friederike M. Dannheim

Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2020 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
SWStephen J. Walsh
Stephen J. Walsh
JBJonathan D. Bargh
Jonathan D. Bargh
FDFriederike M. Dannheim
Friederike M. Dannheim
AHAbigail R. Hanby
Abigail R. Hanby
HSHikaru Seki
Hikaru Seki
DSDavid Spring
David Spring
Antibody–drug conjugates (ADCs) harness the highly specific targeting capabilities of an antibody to deliver a cytotoxic payload to specific cell types. This review summarises the advances made in the construction of homogenous ADCs.

7 May 2021 in Reaction Chemistry & Engineering
Verified
Journal Article
Open access
PDF file
CTConnor J. Taylor
Connor J. Taylor
HSHikaru Seki
Hikaru Seki
FDFriederike M. Dannheim
Friederike M. Dannheim
MWMark J. Willis
Mark J. Willis
GCGraeme Clemens
Graeme Clemens
RBRichard A. Bourne
Richard A. Bourne
We herein report experimental applications of a novel, automated computational approach to chemical reaction network (CRN) identification. This report shows the first chemical applications of an autonomous tool to identify the kinetic model and parameters of a process, when considering both catalytic species and various integer and non-integer orders in the model's rate laws. This kinetic analysis methodology requires only the input of the species within the chemical system (starting materials, intermediates, products, etc.) and corresponding time-series concentration data to determine the kinetic information of the chemistry of interest. This is performed with minimal human interaction and several case studies were performed to show the wide scope and applicability of this process development tool. The approach described herein can be employed using experimental data from any source and the code for this methodology is also provided open-source.

20 July 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
FDFriederike M. Dannheim
Friederike M. Dannheim
SWStephen J. Walsh
Stephen J. Walsh
COCarolina T. Orozco
Carolina T. Orozco
AHAnders Højgaard Hansen
Anders Højgaard Hansen
JBJonathan D. Bargh
Jonathan D. Bargh
DSDavid Spring
David Spring
Tetra-divinylpyrimidine (TetraDVP) linkers offer a method for the generation of antibody conjugates with modular cargo loading and excellent stability via all-in-one disulfide bridging.

29 May 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
RMRulin Ma
Rulin Ma
JYJonathon Young
Jonathon Young
RPRossella Promontorio
Rossella Promontorio
FDFriederike M. Dannheim
Friederike M. Dannheim
CPChristopher C. Pattillo
Christopher C. Pattillo
MWM. Christina White
M. Christina White

13 January 2022 in Chemical Communications
Verified
Journal Article
Open access
PDF file
SWStephen J. Walsh
Stephen J. Walsh
SOSoleilmane Omarjee
Soleilmane Omarjee
FDFriederike M. Dannheim
Friederike M. Dannheim
DCDominique-Laurent Couturier
Dominique-Laurent Couturier
DBDorentina Bexheti
Dorentina Bexheti
DSDavid Spring
David Spring
The development of divinylpyrimidine (DVP) reagents for the synthesis of antibody–drug conjugates (ADCs) with in vivo efficacy and tolerability is reported.

3 December 2025 in Chemical Science
Verified
Journal Article
Open access
PDF file
ACAndrew James Counsell
Andrew James Counsell
SWStephen J. Walsh
Stephen J. Walsh
NANicola Ashman
Nicola Ashman
MPMahri Park
Mahri Park
FDFriederike M. Dannheim
Friederike M. Dannheim
DSDavid Spring
David Spring
Herein we report the development of a novel linker platform for tumour-responsive antibody–drug conjugates.